PubMed:7670114
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 196-201 | gene:6688 | denotes | Spi-1 |
| T1 | 277-293 | disease:C0023440 | denotes | erythroleukemias |
| R1 | T0 | T1 | associated_with | Spi-1,erythroleukemias |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-38 | protein | denotes | hematopoietic transcription factor |
| T2 | 39-43 | protein | denotes | PU.1 |
| T3 | 64-97 | cell_line | denotes | human multiple myeloma cell lines |
| T4 | 99-103 | protein | denotes | PU.1 |
| T5 | 109-143 | protein | denotes | hematopoietic transcription factor |
| T6 | 161-171 | protein | denotes | Ets-family |
| T7 | 196-210 | DNA | denotes | Spi-1 oncogene |
| T8 | 295-299 | protein | denotes | PU.1 |
| T9 | 346-377 | cell_type | denotes | multiple hematopoietic lineages |
| T10 | 401-413 | cell_type | denotes | mature cells |
| T11 | 457-511 | cell_type | denotes | B-cell-and monocyte/macrophage-differentiation lineage |
| T12 | 536-542 | DNA | denotes | Pu box |
| T13 | 557-595 | DNA | denotes | tissue-specific regulatory DNA element |
| T14 | 644-657 | cell_type | denotes | cell lineages |
| T15 | 707-711 | protein | denotes | PU.1 |
| T16 | 761-773 | cell_line | denotes | B-cell lines |
| T17 | 824-840 | cell_line | denotes | early precursors |
| T18 | 844-871 | cell_line | denotes | differentiated plasma cells |
| T19 | 873-882 | RNA | denotes | PU.1 mRNA |
| T20 | 898-902 | protein | denotes | PU.1 |
| T21 | 1035-1045 | cell_line | denotes | cell lines |
| T22 | 1059-1091 | cell_line | denotes | pro-B, pre-B, and mature B cells |
| T23 | 1112-1118 | DNA | denotes | Pu box |
| T24 | 1200-1210 | cell_line | denotes | cell lines |
| T25 | 1240-1267 | cell_line | denotes | multiple myeloma cell lines |
| T26 | 1282-1322 | cell_type | denotes | differentiated, plasma cell-like B cells |
| T27 | 1324-1328 | protein | denotes | PU.1 |
| T28 | 1372-1378 | DNA | denotes | Pu box |
| T29 | 1455-1480 | cell_line | denotes | lymphoblastoid cell lines |
| T30 | 1616-1649 | cell_line | denotes | human multiple myeloma cell lines |
| T31 | 1682-1689 | cell_type | denotes | B cells |
| T32 | 1709-1713 | protein | denotes | PU.1 |
| T33 | 1794-1798 | protein | denotes | PU.1 |
| T34 | 1826-1849 | cell_line | denotes | plasmacytoma cell lines |
| T35 | 1897-1901 | protein | denotes | PU.1 |
| T36 | 1929-1962 | cell_line | denotes | human multiple myeloma cell lines |
| T37 | 2072-2105 | cell_type | denotes | terminally differentiated B cells |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 7670114-2#23#28#gene6688 | 196-201 | gene6688 | denotes | Spi-1 |
| 7670114-2#104#120#diseaseC0023440 | 277-293 | diseaseC0023440 | denotes | erythroleukemias |
| 23#28#gene6688104#120#diseaseC0023440 | 7670114-2#23#28#gene6688 | 7670114-2#104#120#diseaseC0023440 | associated_with | Spi-1,erythroleukemias |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-43 | NP | denotes | The hematopoietic transcription factor PU.1 |
| C2 | 99-103 | NP | denotes | PU.1 |
| C3 | 173-175 | NP | denotes | It |
| C4 | 192-210 | NP | denotes | the Spi-1 oncogene |
| C5 | 212-217 | NP | denotes | which |
| C6 | 295-299 | NP | denotes | PU.1 |
| C7 | 383-386 | NP | denotes | its |
| C8 | 453-511 | NP | denotes | the B-cell-and monocyte/macrophage-differentiation lineage |
| C9 | 513-515 | NP | denotes | It |
| C10 | 522-542 | NP | denotes | the so-called Pu box |
| C12 | 638-657 | NP | denotes | these cell lineages |
| C11 | 544-657 | NP | denotes | an important tissue-specific regulatory DNA element present in a number of genes expressed in these cell lineages |
| C13 | 707-711 | NP | denotes | PU.1 |
| C14 | 750-817 | NP | denotes | a panel of B-cell lines representing different stages of maturation |
| C15 | 873-893 | NP | denotes | PU.1 mRNA expression |
| C16 | 898-923 | NP | denotes | PU.1 DNA binding activity |
| C17 | 1194-1210 | NP | denotes | these cell lines |
| C18 | 1228-1267 | NP | denotes | a number of multiple myeloma cell lines |
| C19 | 1324-1349 | NP | denotes | PU.1 DNA binding activity |
| C20 | 1351-1366 | NP | denotes | mRNA expression |
| C21 | 1455-1480 | NP | denotes | lymphoblastoid cell lines |
| C22 | 1482-1487 | NP | denotes | which |
| C23 | 1612-1649 | NP | denotes | the human multiple myeloma cell lines |
| C24 | 1767-1784 | NP | denotes | the murine system |
| C25 | 1788-1793 | NP | denotes | which |
| C26 | 1794-1798 | NP | denotes | PU.1 |
| C27 | 1929-1962 | NP | denotes | human multiple myeloma cell lines |
| C28 | 2008-2019 | NP | denotes | these cells |
| R1 | C2 | C1 | coref-ident | PU.1,The hematopoietic transcription factor PU.1 |
| R2 | C3 | C2 | coref-pron | It,PU.1 |
| R3 | C5 | C4 | coref-relat | which,the Spi-1 oncogene |
| R4 | C6 | C2 | coref-ident | PU.1,PU.1 |
| R5 | C7 | C6 | coref-pron | its,PU.1 |
| R6 | C9 | C6 | coref-pron | It,PU.1 |
| R7 | C12 | C8 | coref-ident | these cell lineages,the B-cell-and monocyte/macrophage-differentiation lineage |
| R8 | C11 | C10 | coref-appos | an important tissue-specific regulatory DNA element present in a number of genes expressed in these cell lineages,the so-called Pu box |
| R9 | C13 | C6 | coref-ident | PU.1,PU.1 |
| R10 | C17 | C14 | coref-ident | these cell lines,a panel of B-cell lines representing different stages of maturation |
| R11 | C19 | C16 | coref-ident | PU.1 DNA binding activity,PU.1 DNA binding activity |
| R12 | C20 | C15 | coref-ident | mRNA expression,PU.1 mRNA expression |
| R13 | C22 | C21 | coref-relat | which,lymphoblastoid cell lines |
| R14 | C23 | C18 | coref-ident | the human multiple myeloma cell lines,a number of multiple myeloma cell lines |
| R15 | C25 | C24 | coref-relat | which,the murine system |
| R16 | C26 | C13 | coref-ident | PU.1,PU.1 |
| R17 | C27 | C23 | coref-ident | human multiple myeloma cell lines,the human multiple myeloma cell lines |
| R18 | C28 | C27 | coref-ident | these cells,human multiple myeloma cell lines |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-98 | Sentence | denotes | The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines. |
| S2 | 99-172 | Sentence | denotes | PU.1 is a hematopoietic transcription factor belonging to the Ets-family. |
| S3 | 173-294 | Sentence | denotes | It is identical to the Spi-1 oncogene, which is implicated in spleen focus-forming virus-induced murine erythroleukemias. |
| S4 | 295-512 | Sentence | denotes | PU.1 seems to be required for early development of multiple hematopoietic lineages, but its expression in mature cells is preferentially observed in cells of the B-cell-and monocyte/macrophage-differentiation lineage. |
| S5 | 513-658 | Sentence | denotes | It binds the so-called Pu box, an important tissue-specific regulatory DNA element present in a number of genes expressed in these cell lineages. |
| S6 | 659-872 | Sentence | denotes | We have analyzed the expression and activity of PU.1 during human B-cell development using a panel of B-cell lines representing different stages of maturation, from early precursors to differentiated plasma cells. |
| S7 | 873-1092 | Sentence | denotes | PU.1 mRNA expression and PU.1 DNA binding activity, as measured by Northern blot analysis and electrophoretic mobility shift assay, respectively, were evident in cell lines representing pro-B, pre-B, and mature B cells. |
| S8 | 1093-1211 | Sentence | denotes | We could also show Pu box-dependent transactivation of a reporter gene in transient transfections in these cell lines. |
| S9 | 1212-1451 | Sentence | denotes | In contrast, in a number of multiple myeloma cell lines, representing differentiated, plasma cell-like B cells, PU.1 DNA binding activity, mRNA expression, and Pu box-dependent transactivation were absent or detectable at a very low level. |
| S10 | 1452-1595 | Sentence | denotes | In lymphoblastoid cell lines, which exemplify an intermediate stage of B-cell differentiation, a reduced expression and activity were observed. |
| S11 | 1596-1850 | Sentence | denotes | The findings in the human multiple myeloma cell lines represent the first examples of B cells with downregulated PU.1 expression and apparently contradict observations in the murine system in which PU.1 is expressed and active in plasmacytoma cell lines. |
| S12 | 1851-2106 | Sentence | denotes | At present, it is unclear whether the lack of PU.1 expression and activity in human multiple myeloma cell lines represents a malignancy-associated defect in these cells or exemplifies a normal developmental regulation in terminally differentiated B cells. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-38 | protein_family_or_group | denotes | hematopoietic transcription factor |
| T2 | 39-43 | protein_molecule | denotes | PU.1 |
| T3 | 64-97 | cell_line | denotes | human multiple myeloma cell lines |
| T4 | 99-103 | protein_molecule | denotes | PU.1 |
| T5 | 109-143 | protein_family_or_group | denotes | hematopoietic transcription factor |
| T6 | 161-171 | protein_family_or_group | denotes | Ets-family |
| T7 | 196-210 | DNA_domain_or_region | denotes | Spi-1 oncogene |
| T8 | 235-241 | body_part | denotes | spleen |
| T9 | 295-299 | protein_molecule | denotes | PU.1 |
| T10 | 346-377 | cell_type | denotes | multiple hematopoietic lineages |
| T11 | 401-413 | cell_type | denotes | mature cells |
| T12 | 457-488 | cell_type | denotes | B-cell-and monocyte/macrophage- |
| T13 | 488-503 | other_name | denotes | differentiation |
| T14 | 536-542 | DNA_domain_or_region | denotes | Pu box |
| T15 | 557-595 | DNA_family_or_group | denotes | tissue-specific regulatory DNA element |
| T16 | 644-657 | cell_type | denotes | cell lineages |
| T17 | 707-711 | protein_molecule | denotes | PU.1 |
| T18 | 719-743 | other_name | denotes | human B-cell development |
| T19 | 761-773 | cell_line | denotes | B-cell lines |
| T20 | 824-840 | cell_line | denotes | early precursors |
| T21 | 844-871 | cell_line | denotes | differentiated plasma cells |
| T22 | 873-877 | protein_molecule | denotes | PU.1 |
| T23 | 898-902 | protein_molecule | denotes | PU.1 |
| T24 | 940-962 | other_name | denotes | Northern blot analysis |
| T25 | 967-1003 | other_name | denotes | electrophoretic mobility shift assay |
| T26 | 1035-1045 | cell_line | denotes | cell lines |
| T27 | 1112-1118 | DNA_domain_or_region | denotes | Pu box |
| T28 | 1200-1210 | cell_line | denotes | cell lines |
| T29 | 1240-1267 | cell_line | denotes | multiple myeloma cell lines |
| T30 | 1282-1322 | cell_type | denotes | differentiated, plasma cell-like B cells |
| T31 | 1324-1328 | protein_molecule | denotes | PU.1 |
| T32 | 1351-1366 | other_name | denotes | mRNA expression |
| T33 | 1372-1378 | DNA_domain_or_region | denotes | Pu box |
| T34 | 1455-1480 | cell_line | denotes | lymphoblastoid cell lines |
| T35 | 1523-1529 | other_name | denotes | B-cell |
| T36 | 1530-1545 | other_name | denotes | differentiation |
| T37 | 1557-1567 | other_name | denotes | expression |
| T38 | 1616-1621 | cell_line | denotes | human |
| T39 | 1622-1649 | cell_line | denotes | multiple myeloma cell lines |
| T40 | 1682-1689 | cell_type | denotes | B cells |
| T41 | 1695-1708 | other_name | denotes | downregulated |
| T42 | 1709-1713 | protein_molecule | denotes | PU.1 |
| T43 | 1771-1784 | other_name | denotes | murine system |
| T44 | 1794-1798 | protein_molecule | denotes | PU.1 |
| T45 | 1826-1849 | cell_line | denotes | plasmacytoma cell lines |
| T46 | 1897-1901 | protein_molecule | denotes | PU.1 |
| T47 | 1929-1934 | cell_line | denotes | human |
| T48 | 1935-1962 | cell_line | denotes | multiple myeloma cell lines |
| T49 | 2072-2097 | cell_type | denotes | terminally differentiated |
| T50 | 2098-2105 | cell_type | denotes | B cells |